Purchase Order 75N91020P00290
Award Date
6/1/20
Potential Completion Date
11/29/24
Potential Value
$130K
Federal Agency
National Cancer Institute
Awardee
Emulate Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order award by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract is a Total Small Business Set-Aside with a potential value of $204,922.00 and a completion date of March 19, 2024. The award is based on a combined synopsis/solicitation for Emulate Bio Organ-On-AChip reagent kits. Emulate's organ-on-a-chip...
This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Emulate Inc., a for-profit small business organization. The contract, valued at $24,997.00, is for the delivery of biological kits and reagents, which are likely components of Emulate's organ-on-a-chip technology products used to model human biology. These products support the National Cancer Institute's initiatives in areas such as...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,616 purchase order to Emulate Inc., doing business as Emulate, located in Rockville, Maryland. The contract is for a one-year period starting December 20, 2023 through December 19, 2024 to provide a complete human emulation system as a service. No subcontractors or set aside designations were identified. The National Cancer Institute supports research to advance cancer prevention,...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Emulate Inc., a for-profit small business. The contract, valued at $145,260.00, is for the delivery of Emulate's CHIP-S1 Stretchable Chip, a product in their organ-on-a-chip technology line. This technology supports various FDA and HHS initiatives in areas such as personalized medicine, biosurveillance, infectious disease...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Emulate Inc., doing business as Emulate, a for-profit organization. The $200,300.00 contract is for the provision of a human emulation system, which is a set-aside for small businesses. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Emulate Inc. for the trade-in of a Zoe Culture Module 2. The contract has a ceiling value of $180,800 and a completion date of September 16, 2024. Emulate Inc., a for-profit organization that develops organ-on-a-chip technology, has received prior contract and grant awards from various federal agencies,...
This federal contract award, valued at $73,050.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., a for-profit organization specializing in organ-on-a-chip technology. The award is for a Restricted Lab Service Program to provide four Zoe CM2 Culture Modules for Organ Chips. The contract is a Firm Fixed Price Purchase Order with a completion date of September 16, 2025. This award does not utilize a set-aside designation. Emulate Inc., also known...
This federal contract award, valued at $75,000.00, was issued by the Uniformed Services University of the Health Sciences, a defense agency, to Emulate Inc. (doing business as Emulate), a biotechnology company specializing in organ-on-chip technology. The contract is for the delivery of 3-dimensional organ-on-chip technology to support the agency's research initiatives. This is a firm fixed-price purchase order contract with an ultimate completion date of August 31, 2020. The contract was not...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order contract to Emulate Inc., a for-profit small business, with a potential value of $218,100.00. The contract is for the delivery of two (2) each of the Human Emulation System ZOE Culture Module 2 and two (2) each of the Orb Hub Module. Emulate's organ-on-a-chip technology is designed to model human biology and supports federal initiatives in areas like personalized medicine,...